Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Imperial Brands Plc | IMB | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -4.00 | -0.16% | 2,510.00 | 10:35:43 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2,521.00 | 2,496.00 | 2,521.00 | 2,514.00 |
| Industry Sector |
|---|
| TOBACCO |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 08/10/2024 | Interim | GBP | 0.4008 | 30/09/2025 | 30/09/2025 | |
| 08/10/2024 | Interim | GBP | 0.4008 | 30/06/2025 | 30/06/2025 | |
| 15/05/2024 | Final | GBP | 0.5426 | 20/02/2025 | 21/02/2025 | 31/03/2025 |
| 15/05/2024 | Interim | GBP | 0.5426 | 28/11/2024 | 29/11/2024 | 31/12/2024 |
| 15/05/2024 | Interim | GBP | 0.2245 | 22/08/2024 | 23/08/2024 | 30/09/2024 |
| 15/05/2024 | Interim | GBP | 0.2245 | 23/05/2024 | 24/05/2024 | 28/06/2024 |
| 14/11/2023 | Final | GBP | 0.5182 | 15/02/2024 | 16/02/2024 | 28/03/2024 |
| 14/11/2023 | Interim | GBP | 0.5182 | 23/11/2023 | 24/11/2023 | 29/12/2023 |
| 16/05/2023 | Interim | GBP | 0.2159 | 17/08/2023 | 18/08/2023 | 29/09/2023 |
| 16/05/2023 | Interim | GBP | 0.2159 | 25/05/2023 | 26/05/2023 | 30/06/2023 |
| 15/11/2022 | Final | GBP | 0.4932 | 16/02/2023 | 17/02/2023 | 31/03/2023 |
| 15/11/2022 | Interim | GBP | 0.4931 | 24/11/2022 | 25/11/2022 | 30/12/2022 |
| 17/05/2022 | Interim | GBP | 0.2127 | 18/08/2022 | 19/08/2022 | 30/09/2022 |
| 17/05/2022 | Interim | GBP | 0.2127 | 26/05/2022 | 27/05/2022 | 30/06/2022 |
| 16/11/2021 | Final | GBP | 0.4848 | 17/02/2022 | 18/02/2022 | 31/03/2022 |
| 16/11/2021 | Interim | GBP | 0.4848 | 25/11/2021 | 26/11/2021 | 31/12/2021 |
| 18/05/2021 | Interim | GBP | 0.2106 | 19/08/2021 | 20/08/2021 | 30/09/2021 |
| 18/05/2021 | Interim | GBP | 0.2106 | 27/05/2021 | 28/05/2021 | 30/06/2021 |
| 17/11/2020 | Final | GBP | 0.4801 | 18/02/2021 | 19/02/2021 | 31/03/2021 |
| Interim | GBP | 0.48 | 26/11/2020 | 27/11/2020 | 31/12/2020 | |
| Interim | GBP | 0.48 | 26/11/2020 | 27/11/2020 | 31/12/2020 | |
| Interim | GBP | 0.2085 | 20/08/2020 | 21/08/2020 | 30/09/2020 | |
| Interim | GBP | 0.2085 | 28/05/2020 | 29/05/2020 | 30/06/2020 | |
| 08/07/2019 | Final | GBP | 0.7201 | 20/02/2020 | 21/02/2020 | 31/03/2020 |
| 05/11/2019 | Final | GBP | 0.7201 | 20/02/2020 | 21/02/2020 | 31/03/2020 |
| Top Posts |
|---|
Posted at 20/11/2024 12:03 by marktime1231 An inbox alert this morning that IMB has hit £25 price target. Do I want to sell?No. Not with those big dividends on the way. Nice problem to have though. |
Posted at 19/11/2024 13:41 by marktime1231 Using that word "accelerated" again to describe modest gains. I wonder what the buzzword for the next 5 year plan will be. More of the same? There is clearly scope for ongoing £1B+ pa buybacks or debt reduction, and slowly enhanced dividends, but we will have to wait until a Capital Markets Day next March to hear which direction they want to go. Radical restructuring or capex plans not on the cards, nothing broken to fix.Very impressed with the financial performance and continuing growth by acquisition of the panEuropean distribution business Logista. Also pleased to note that gross debt actually reduced, by around £100M, and average interest cost is still only 4.2%, but with upward pressure. Not impressed that the outlook for NGP is merely to reduce losses. Come on have the ambition to get to scale and turn a profit on its own footing, like other companies are doing or have done already. Looking at the pension scheme situation to see if there is a hidden nugget. The largest UK scheme in reasonably good shape, but a horrible unfunded scheme in Germany is a drag. No imminent windfall expected. So there is nothing particularly interesting or exciting in the results or outlook, just dull solid returns on the horizon. And that quite rightly is enough to make IMB look an increasingly attractive long term income play. |
Posted at 12/11/2024 15:19 by laurence llewelyn binliner #Fenners66, yup 8 months of dividends for both, maybe if you cover off PM/MO it would be a clean sweep and 12 months, I only have IMB/BATS covered and that will do me well for the sector.. :o) |
Posted at 18/10/2024 15:18 by marktime1231 So BAT in Canada (a subsidiary previously called Imperial Tobacco but IMB has no residual exposure that I can find) is on the hook for about £6B which it says it will settle from cash reserves and future cash flow. News which does not seem to have been fully priced in, off about £1 making it the FTSEs worst performer.I wonder how much BAT had set aside in provisions, how much it has reserved in cash and how long it will take future cash flow from Canadian operations to settle the award. BAT has been pledging all available cash to buybacks to try and keep up with IMB, including proceeds from disposals. Under pressure from too many directions unless it can find more dosh. I wonder what is the extent and status of similar litigation around the world, all big tobacco must be exposed. A sobering prospect we should not ignore even while IMB seems to be on the up and up. |
Posted at 09/10/2024 07:16 by muscletrade Proactive Investors - ESG advocates close your ears, but Imperial Brands PLC (LON:IMB) has proven once again that Big Tobacco stocks are some of the higher income generators on the market.Not only does the owner of Golden Virginia and Davidoff have an estimated 7% dividend yield, it is also on track to repurchase another 7% of its outstanding shares through newly announced buybacks. Rounding out a tidy 7-7-7, Panmure Liberum analysts noted that Imperial’s share price is currently trading at around seven times earnings. Analysts see this as “hugely undervalued”. Such is Imperial’s appetite for buybacks, that according to Panmure: “ Repurchases to date have retired 11.2% of the opening share count, or put another way, in two years Imperial has bought more shares than are owned by all but one of its institutional shareholders.” This shrinking equity base and progressive dividend policy is thanks to what Panmure Liberum analysts call “prodigious Although NGPs – being the array of vapes, heated products and pouches that Imperial sells – remains a loss-making segment, these losses continue to narrow while sales continue to enjoy double-digit growth. The wider group remains highly profitable regardless. “This is the result of continued strong pricing in cigarettes (once again belying the siren voices that cigarette pricing is ‘over),” said Panmure. All in all, “the company is doing everything right”, reckon Panmure analysts. Not that ESG advocates would agree. |
Posted at 09/10/2024 06:53 by xtrmntr Hargreaves: Imperial Brands lights up returns Imperial Brands (IMB) is driving growth in new products and 'legacy' tobacco, allowing it to 'up the ante' with shareholder returns, says Hargreaves Lansdown.The Citywire Elite Companies AAA-rated company delivered growth in next-generation products and tobacco revenues last year, in line with expectations. This allowed it to increase the full-year 2024 dividend by 4.5% to 153.43p it said dividends and buybacks will be increased £400m to £2.8bn next year, equal to a distribution yield of 15%.Analyst Derren Nathan said the group 'managed to drive growth not only in its fledgling next-generation brands, but also in "legacy" tobacco products which still make up the lion's share of the business'.Imperial Brands is expecting a 'significant acceleration' in next-generation products with revenue growth of 20%-30%.'Strong cash conversion is allowing it to up the ante on payouts to shareholders,' said Nathan, who added that next year's dividend target equates to about 176p per share but 'could end up being closer to 200p depending on the price which buybacks are effected at'.The shares gained 4.1% to £22.36 yesterday. |
Posted at 08/10/2024 12:45 by marktime1231 Yes huckers I have been watching for that news too, we will find out in the report.A bit wrinkled that they keep using the word "accelerated" to describe performance which remains a tussle between falling volumes and rising prices. A pity vaping is still not making a positive contribution. But at last we are getting decent bottom line improvement feeding through to the dividend up to 160p in equal quarters. The real boost is to the buyback programme which gets priority over dividends and debt reduction. Another 7% or so reduction on the way. BAT just can't compete with that, folks chasing a rainbow over there instead of banking here. The IMB board certain that their stock is way undervalued and determined to do everything to support it. Until a bid lands I suppose. Meanwhile we can hope for further strong share price progress. |
Posted at 03/9/2024 10:52 by marktime1231 The IMB share price cycle might have peaked for now, or it may well continue upwards. We are heading in to big dividend season so let's watch and see, I'm hoping for more progress.The upward pressure comes from the significant ongoing buyback, the belief at some stage there will be industry consolidation eg a merger with BAT, and the excellent yield while interest rates are starting to fall. The p/e here still says IMB is cheap rather than a risk-adjusted full price, whatever that is ... £24-25 perhaps. It may well be the case that IMB's ability to price up to counter falling volume will run out of steam. I don't buy the "accelerated" decline scenario, but yes tobacco volumes will continue to fall. Judging when to exit is always hard, but I understand the sentiment that at some stage we will all want to be out of this death stock. I have taken considerable capital gain by selling down some of the stock added when the share price was dirt cheap 4 and 5 years ago. Keeping the rest for now. The pre-finals trading update on 8 October worth waiting for. Of course taking the opportunity to pursue stocks where you see a better upside is a great reason to move on. Where to invest to capture the boom from falling interest rates is something we should all be considering. |
Posted at 02/9/2024 22:51 by wunderbar I last posted on this bb on 22 Nov 2022 with the share price at 2185p. I was optimistic we might hit my breakeven/exit point 2400p within 3-6 months given positive momentum at the time. Instead, it turned out to be yet another false dawn. As it transpired, 2185p turned out to be the high point of 2022, thereafter the share price embarked on a 10 month steady decline losing 632p [-29%] bottoming out at 1554p in Oct 2023. Talk about a kick in the b0ll0x.During this period I added to my position to get my average down to 2280p. Today, almost 7 years after my initial purchase, I finally pulled the trigger and bailed out at 2193p. I mentioned in my last post I was determined to claw back my entire stake despite being comfortably in profit if I included dividend income over the years. However, I reluctantly accepted defeat and booked a capital loss of 3.9%. If I factor in dividend income [inc. capital loss] it works out my investment has generated an average yield of 4.76% per year. All in all IMB has been a poor investment for me. As I’ve previously mentioned, my cardinal sin was averaging down too frequently during 2018-2019, this gung-ho approach spectacularly backfired with the share price falling over 1000p during these two years. Who remembers the cries of “it can’t possibly go below 2500p” and “surely won’t go under 2000p”. We all know how that turned out. Some might ask why have I sold up when the share price is only c.90p from my break even point. Well, plenty reasons. First and foremost, IMB has been on a fantastic run since April, climbing 532p [YTD low: 1662p / high: 2194p]. I just can’t see this rise continuing indefinitely, in my opinion it’s starting to look toppy hence decision to sell. Also note IMB hit a five year high today [albeit by a narrow margin] of 2194p before falling back to close at 2183p. I’m very wary we’re back to a similar level seen two years ago when share price peaked at 2185p, then fell off a cliff. Right now it’s hard to tell if IMB’s share price is consolidating at this level before its next leg up, or if we’re now at a point where a correction is imminent. Obviously I’m banking on the latter. But if we do see c.2300p in coming weeks/months then so be it. You win some, you lose some. My priority here is two-fold; firstly, protect my capital, and secondly, reduce my exposure to tobacco sector noting I also hold BATS which I think has more upside potential, a superior dividend, and far greater NGP exposure [noting BATS NGP segment achieved a positive operating contribution in 2023, two years earlier than it originally estimated]. I’m also wary the FTSE is not far off its all-time high. At 8364 it looks bloated to me and I’m worried a sell-off would possibly wipe-out a large portion of IMB’s gains. I don’t want to chance hanging around for another sharp fall in share price I should add it was never my intention to build a significant stake in IMB [significant in relation to size of my portfolio]. This being a result of overzealous buying in 2018-2019. Too many eggs in one basket is never a good idea, something I learned the hard way during Covid crash in March 2020 when IMB tanked all the way down to 1200p. I'm also mindful of future government intervention, further tightening of regulations. In the US the FDA's planned ban on menthol cigarettes is still pending but I'd expect a decision in the next 12-18 months. This is more pertinent to British American Tobacco. Given the accelerated decline in cigarette volumes, particularly US/UK, I have real concerns IMB’s Next Generation Products are not growing fast enough to counter this fall. In May, IMB reported NGP revenues jumped 16.8%, nevertheless this category is still loss making. I fear it's going to take a very long time to accelerate NGP profits to a level comparable to cigarettes. I think NGP growth rate needs to be significantly higher otherwise this could become a major issue at some point. They can't keep plugging the gap with price increases. I came across a Sharecast article back in May titled “pressures are building for Imperial Brands, says Jefferies”. Below are some snippets. Jefferies has lifted its target price for Imperial Brands following a strong set of first-half results from the cigarette, tobacco and vape group last week, but has maintained a 'hold' rating, saying that pressures are building for the company. The broker hiked the target price for the shares from 1,710p to 1,850p. "IMB's 1H24 was very robust. We continue to feel it is over-earning, however, which could mean difficulties at some point," Jefferies said, highlighting two key areas of risk in combustibles and reduced risk products (RRP). In combustibles, the broker said the industry volume backdrop in Imperial's core markets "continues to get worse and we don't see things improving", with first-half volumes in Australia, the UK and US down 25.3%, 15.2% and 8.7% respectively. "The key metric to assess, for us, is its fair share of RRP relative to cigarettes. This is a minimum requirement, in our view. IMB are way away from this hurdle rate on our estimates, with estimated US and EU combustible share in FY23 at 15.0% vs RRP stick equivalent share at 1.4%," Jefferies said. Improving this, the broker said, will require a material uplift in spend. END To close off, I must admit it seems strange no longer having IMB in my portfolio. It was a tough decision to sell but I feel I can put the proceeds to better use elsewhere, specifically targeting companies with potential to make significant capital gains. At this moment in time my top choices are BP, IPO, PZC, CNA and ADIG [all of which I already hold]. But there are plenty more on my radar such as Reckitt Benckiser, Diageo and Burberry to name a few. Would I consider buying back into IMB? Absolutely. But definitely a much smaller stake, and only at a price point I feel offers value for money. For me that would be 1600-1750p. Until then! |
Posted at 08/2/2024 13:14 by marktime1231 Well I don't see what was particularly exciting in BATs results. The thing which may have caused the share price boost is the announcement that it is looking again how to extract value from its India business ITC where it has a 29% stake which might be worth around $18B. It has been under pressure to sell up and reduce group debt but cited regulatory issues. Perhaps those hurdles are now being overcome.Modest revenue and profit performance, a dividend limping forward. Strong organic debt reduction progress, average interest rate has jumped from 4% to 5.2% (which compares to IMBs at roughly 4.8% in FY23), but still heavily saddled with about £36B borrowings (compared to IMBs approx £9.5B), it cannot commit to better dividend progress or buybacks unlike IMB. Next gen has started to make a tiny profit contribution. A 2% increase in quarterly dividends is below inlation. BAT yields about 9.5% compared to IMBs 8% as things stand, so maybe BAT was due an uplift. Quite why that is hurting IMB share price today who knows. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
